Learn more about the pathophysiology of sepsis and the various changes which occur at an immune system level; in addition to how current research findings on disease stratification could help in improving sepsis care through timely and endotype-tailored interventions.

Learning Objectives:

• Identify specific factors in both hosts and pathogens which can impact disease progression and patient outcomes.
• Acknowledge how the identification of endotypes based on inflammatory proteins in moderately ill patients with severe infection can be useful for patient stratification in sepsis.
• Understand the pathophysiology of common immune response pathways which occur during severe infections, and how advancements in the study of various proteins might help in targeting better treatment options for septic patients with severe infections.
• Comprehend what platform trials are and how they are used; in addition to learning about the possible pros and cons associated with such trails in the field of sepsis research.

Instructors:

• Nathan Nielsen, Global Sepsis Alliance, United States of America (moderator).
• Jennifer Muszynski, Nationwide Children’s, United States of America.
• Mihai Netea, Radboud UMC, The Netherlands.
• Evangelos J. Giamarellos-Bourboulis, European Sepsis Alliance, Greece.
• Eirini Christaki, University of Ioannina, Greece.
• Niels Riedemann, CEO InflaRx, Germany.

Course Information

Course Instructor

4th WSC Author